Assignee
EMCURE PHARMACEUTICALS LTD
IN·16 granted patents·8 pending applications·16 citations·filing 2003–2022
Top patents by PatentIndex Score
24 records- 0180US10583101B2Lipid formulations of carmustineEMCURE PHARMACEUTICALS LTD·Filed 2017·Granted Mar 10, 2020·2 cites·18 claims
- 0277US8030480B2Cost-effective process for preparation of manufacture of iron sucroseEMCURE PHARMACEUTICALS LTD·Filed 2005·Granted Oct 4, 2011·7 cites·18 claims
- 0366US6982349B1Process for producing atenolol of high optical purityEMCURE PHARMACEUTICALS LTD·Filed 2003·Granted Jan 3, 2006·6 cites·8 claims
- 0465US11865206B2Stable ready-to-use carmustine pharmaceutical compositionEMCURE PHARMACEUTICALS LTD·Filed 2022·Granted Jan 9, 2024·0 cites·10 claims
- 0565US9643914B2Fingolimod hydrochloride processEMCURE PHARMACEUTICALS LTD·Filed 2014·Granted May 9, 2017·1 cites·10 claims
- 0656US12427127B2Carmustine formulationEMCURE PHARMACEUTICALS LTD·Filed 2019·Granted Sep 30, 2025·0 cites·5 claims
- 0755US2023210793A1Method for rapid infusion of carmustineEMCURE PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0854US2021322304A1Stable ready-to-use carmustine pharmaceutical compositionEMCURE PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 0953US2021038543A1Kit for preparing injectable carmustine solutionsEMCURE PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1052US7858801B2Process for producing enantiomer of amlodipine in high optical purityEMCURE PHARMACEUTICALS LTD·Filed 2005·Granted Dec 28, 2010·0 cites·7 claims
- 1150US10278946B2Liquid formulation of cabazitaxelEMCURE PHARMACEUTICALS LTD·Filed 2018·Granted May 7, 2019·0 cites·4 claims
- 1250US9403809B2Synthesis of raltegravirEMCURE PHARMACEUTICALS LTD·Filed 2012·Granted Aug 2, 2016·0 cites·13 claims
- 1349US9475799B1Synthesis of RaltegravirEMCURE PHARMACEUTICALS LTD·Filed 2016·Granted Oct 25, 2016·0 cites·5 claims
- 1448US10508075B2Process for preparation of trientine dihydrochlorideEMCURE PHARMACEUTICALS LTD·Filed 2016·Granted Dec 17, 2019·0 cites·5 claims
- 1548US2020108010A1Kit for preparing injectable carmustine solutionsEMCURE PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1645US10759738B2Process for preparation of isoproterenol hydrochlorideEMCURE PHARMACEUTICALS LTD·Filed 2018·Granted Sep 1, 2020·0 cites·10 claims
- 1744US9522924B1Pyridone derivatives as acid secretion inhibitors and process for preparation thereofEMCURE PHARMACEUTICALS LTD·Filed 2016·Granted Dec 20, 2016·0 cites·16 claims
- 1840US9447094B2Pyridone derivatives as acid secretion inhibitors and process for preparation thereofEMCURE PHARMACEUTICALS LTD·Filed 2015·Granted Sep 20, 2016·0 cites·16 claims
- 1937US9919993B2Process for preparation of acitrecinEMCURE PHARMACEUTICALS LTD·Filed 2015·Granted Mar 20, 2018·0 cites·7 claims
- 2037US2018311203A1Liquid formulation of cabazitaxelEMCURE PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 2136US10556851B2Process for preparation of prostacyclin derivativesEMCURE PHARMACEUTICALS LTD·Filed 2017·Granted Feb 11, 2020·0 cites·12 claims
- 2233US2019309014A1Process for preparation of icatibant acetateEMCURE PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 2332US2019269616A1Sterile parenteral suspensionsEMCURE PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 2428US2019031665A1Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancerEMCURE PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EMCURE PHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →